Weiterleitung von Verdachtsfallmeldungen aus der SafeVac 2.0-Studie an Eudravigilance

This procedure concerns the forwarding of suspected case reports from the SafeVac 2.0 study to the Eudravigilance database. This ensures that safety data from vaccine studies is centrally collected and analyzed. This affects patients participating in the SafeVac 2.0 study and healthcare professionals reporting adverse events. It aims to improve vaccine safety monitoring across the EU.